Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsPOWDER, FOR SUSPENSIONGeneric

SODIUM ZIRCONIUM CYCLOSILICATE

SODIUM ZIRCONIUM CYCLOSILICATE

Standard Dose
10G
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary

Approval overview SODIUM ZIRCONIUM CYCLOSILICATE is listed in Drugs@FDA under application 217558 (ANDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient SODIUM ZIRCONIUM CYCLOSILICATE Form and strength POWDER, FOR SUSPENSION - 10G Sponsor ALKEM LABS LTD Submission history Latest submission status date: 2025-10-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview SODIUM ZIRCONIUM CYCLOSILICATE is listed in Drugs@FDA under application 217558 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient SODIUM ZIRCONIUM CYCLOSILICATE Form and strength POWDER, FOR SUSPENSION - 10G Sponsor ALKEM LABS LTD Submission history Latest submission status date: 2025-10-08 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: None (Tentative Approval)
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.